Key Insights

Highlights

Treatment Research

1 treatments under study, led by Observation

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Observation1

Active Sponsors

  • Neuroscience Technologies S.L.P1
  • King's College London1
  • University of Oxford1
  • NYU Langone Health1

Top Investigators

Related Conditions

  • Familial Dysautonomia Rileyday Syndrome1
  • Chronic Pain1
  • Erythromelalgia1
  • Hereditary Sensory And Autonomic Neuropathy 31
  • Pain Insensitivity Congenital1

Activity Timeline